Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels

J Neurosci. 2007 Aug 1;27(31):8250-60. doi: 10.1523/JNEUROSCI.1800-07.2007.

Abstract

Recent studies have demonstrated an important role for T-type Ca2+ channels (T-channels) in controlling the excitability of peripheral pain-sensing neurons (nociceptors). However, the molecular mechanisms underlying the functions of T-channels in nociceptors are poorly understood. Here, we demonstrate that reducing agents as well as endogenous metal chelators sensitize C-type dorsal root ganglion nociceptors by chelating Zn2+ ions off specific extracellular histidine residues on Ca(v)3.2 T-channels, thus relieving tonic channel inhibition, enhancing Ca(v)3.2 currents, and lowering the threshold for nociceptor excitability in vitro and in vivo. Collectively, these findings describe a novel mechanism of nociceptor sensitization and firmly establish reducing agents, as well as Zn2+, Zn2+-chelating amino acids, and Zn2+-chelating proteins as endogenous modulators of Ca(v)3.2 and nociceptor excitability.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, T-Type / physiology*
  • Cell Line
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / physiology
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nociceptors / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Reducing Agents / pharmacology*
  • Zinc / pharmacology*

Substances

  • Cacna1h protein, mouse
  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • Reducing Agents
  • Zinc